GeoVax Labs (GOVX) Files Form 25 to Remove Listing on Nasdaq

GeoVax Labs, Inc. (GOVX) submitted a Form 25 notification regarding removal of a class of its securities from listing and/or registration on the Nasdaq Stock Market LLC.

Rhea-AI Filing Summary

GeoVax Labs, Inc. (GOVX) submitted a Form 25 notification regarding removal of a class of its securities from listing and/or registration on the Nasdaq Stock Market LLC. The filing identifies the issuer's principal office in Smyrna, Georgia and includes Nasdaq's certification that it has complied with the applicable rule provisions for striking the class from the Exchange. The form references rule provisions under 17 CFR 240.12d2-2 and notes Form 25 and an attached notice satisfy related procedural requirements.

Positive

• None.

Negative

• Form 25 notification indicates removal of a class of GeoVax securities from Nasdaq
• Filing lacks disclosure of the reason for removal and any effective date

Insights

Exchange Compliance Analyst

Form 25 filed to remove a class of GeoVax securities from Nasdaq listing.

The filing is an administrative notification that the Exchange has initiated or recognized removal of the specified class of securities under 17 CFR 240.12d2-2. The document confirms procedural compliance by Nasdaq but does not disclose the underlying reason for removal or whether the withdrawal is voluntary.

This is material to investors because a removal from listing affects trading venue and visibility; the filing itself is procedural and contains no financial metrics or dates beyond the issuer address and contact details.

Corporate Secretary / Regulatory Specialist

Nasdaq certified compliance with rules for striking the class from listing; Form 25 and notice filed.

The filing states Nasdaq relied on provisions of 17 CFR 240.12d2-2 and that the Form 25 plus attached notice meets the applicable notification requirements. There is no statement in the filing about whether the issuer or the Exchange initiated the action or any effective delisting date.

If readers need next steps, they must consult additional filings or Nasdaq notices because this document does not provide timing, reason, or market-impact details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did GeoVax Labs (GOVX) file with the SEC?

GeoVax Labs filed a Form 25 notification concerning removal of a class of its securities from listing and/or registration on the Nasdaq Stock Market LLC.

Does the Form 25 state why GOVX securities are being removed from Nasdaq?

No. The filing certifies procedural compliance under 17 CFR 240.12d2-2 but does not disclose the reason for removal.

Does the Form 25 include an effective delisting date for GOVX?

The provided filing text does not include any effective delisting date or timing for the removal.

Who certified compliance for the Form 25 filing?

The filing indicates Nasdaq Stock Market LLC certified it has reasonable grounds and complied with applicable rule provisions to file the Form 25.

Where is GeoVax Labs' principal office listed in the filing?

The filing lists the issuer's principal executive office at 1900 Lake Park Drive Suite 380, Smyrna, Georgia 30080 and provides a telephone number.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/29/2025 - 04:48 PM EDT Learn about SEC filing dates

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-39563

Issuer:	GeoVax Labs, Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	1900 Lake Park Drive Suite 380
	Smyrna	GEORGIA	30080
Telephone number:					6,783,847,220

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Warrants

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-09-29	By	Tara Petta		AVP
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.